JPS504053A - - Google Patents
Info
- Publication number
- JPS504053A JPS504053A JP48072183A JP7218373A JPS504053A JP S504053 A JPS504053 A JP S504053A JP 48072183 A JP48072183 A JP 48072183A JP 7218373 A JP7218373 A JP 7218373A JP S504053 A JPS504053 A JP S504053A
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
- C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
- C07D233/12—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D233/14—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26664072A | 1972-06-27 | 1972-06-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS504053A true JPS504053A (en) | 1975-01-16 |
| JPS5438097B2 JPS5438097B2 (en) | 1979-11-19 |
Family
ID=23015387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP7218373A Expired JPS5438097B2 (en) | 1972-06-27 | 1973-06-26 |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS5438097B2 (en) |
| AT (1) | AT323145B (en) |
| AU (1) | AU472375B2 (en) |
| BE (1) | BE801440A (en) |
| CA (1) | CA1012159A (en) |
| CH (1) | CH581605A5 (en) |
| DE (1) | DE2331665C2 (en) |
| ES (1) | ES416311A1 (en) |
| FR (1) | FR2190451B1 (en) |
| GB (1) | GB1377316A (en) |
| IL (1) | IL42472A (en) |
| NL (1) | NL175910C (en) |
| ZA (1) | ZA733992B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101366296B1 (en) * | 2012-03-07 | 2014-02-21 | 주식회사 포스코 | Constructing method For fireproof material |
| JP2016130241A (en) * | 2016-02-05 | 2016-07-21 | テックフィールズ バイオケム カンパニー リミテッド | Aryl- and heteroaryl-propionic acid positively charged water-soluble prodrug having very fast skin permeation rate |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1508988A (en) * | 1987-04-27 | 1988-10-27 | Syntex Pharmaceuticals International Ltd. | Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal antiinflammatory drugs |
| CA2660814C (en) * | 2006-08-15 | 2017-07-18 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI41272B (en) * | 1963-05-02 | 1969-06-30 | Parke Davis & Co | |
| ZA701191B (en) * | 1969-03-24 | 1971-09-29 | Syntex Corp | 2-(6-substituted-2'-naphthyl)acetic acid esters and process for producing same |
-
1973
- 1973-06-11 CA CA173,695A patent/CA1012159A/en not_active Expired
- 1973-06-11 IL IL42472A patent/IL42472A/en unknown
- 1973-06-12 ZA ZA00733992A patent/ZA733992B/en unknown
- 1973-06-13 GB GB2814473A patent/GB1377316A/en not_active Expired
- 1973-06-14 AU AU56903/73A patent/AU472375B2/en not_active Expired
- 1973-06-15 AT AT528473A patent/AT323145B/en not_active IP Right Cessation
- 1973-06-22 DE DE2331665A patent/DE2331665C2/en not_active Expired
- 1973-06-26 JP JP7218373A patent/JPS5438097B2/ja not_active Expired
- 1973-06-26 BE BE132718A patent/BE801440A/en not_active IP Right Cessation
- 1973-06-26 ES ES416311A patent/ES416311A1/en not_active Expired
- 1973-06-26 NL NLAANVRAGE7308876,A patent/NL175910C/en not_active IP Right Cessation
- 1973-06-26 FR FR7323264A patent/FR2190451B1/fr not_active Expired
- 1973-06-27 CH CH939073A patent/CH581605A5/xx not_active IP Right Cessation
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101366296B1 (en) * | 2012-03-07 | 2014-02-21 | 주식회사 포스코 | Constructing method For fireproof material |
| JP2016130241A (en) * | 2016-02-05 | 2016-07-21 | テックフィールズ バイオケム カンパニー リミテッド | Aryl- and heteroaryl-propionic acid positively charged water-soluble prodrug having very fast skin permeation rate |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2190451B1 (en) | 1976-12-31 |
| JPS5438097B2 (en) | 1979-11-19 |
| BE801440A (en) | 1973-12-26 |
| FR2190451A1 (en) | 1974-02-01 |
| ZA733992B (en) | 1975-01-29 |
| NL175910C (en) | 1985-01-16 |
| NL7308876A (en) | 1974-01-02 |
| CA1012159A (en) | 1977-06-14 |
| AU472375B2 (en) | 1976-05-20 |
| CH581605A5 (en) | 1976-11-15 |
| ES416311A1 (en) | 1976-05-16 |
| NL175910B (en) | 1984-08-16 |
| IL42472A0 (en) | 1973-08-29 |
| AT323145B (en) | 1975-06-25 |
| IL42472A (en) | 1977-01-31 |
| AU5690373A (en) | 1974-12-19 |
| GB1377316A (en) | 1974-12-11 |
| DE2331665C2 (en) | 1983-04-21 |
| DE2331665A1 (en) | 1974-01-17 |